sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
natriumoxybat "kalceks" 500 mg/ml oral opløsning
kalceks as - natriumoxybat - oral opløsning - 500 mg/ml
arixobat 500 mg/ml oral opløsning
aristo pharma gmbh - natriumoxybat - oral opløsning - 500 mg/ml
tolak 40 mg/g creme
pierre fabre dermatologie - fluoruracil - creme - 40 mg/g
tolak 40 mg/g creme
epione medicine aps - fluoruracil - creme - 40 mg/g
tolak 40 mg/g creme
orifarm a/s - fluoruracil - creme - 40 mg/g
tolak 40 mg/g creme
nordic prime aps - fluoruracil - creme - 40 mg/g
tolak 40 mg/g creme
2care4 aps - fluoruracil - creme - 40 mg/g
tolak 40 mg/g creme
medartuum ab - fluoruracil - creme - 40 mg/g
elidel 1 % creme
viatris aps - pimecrolimus - creme - 1 %